Literature DB >> 3597218

Effects of exercise and conditioning on clotting and fibrinolytic activity in men.

E W Ferguson, L L Bernier, G R Banta, J Yu-Yahiro, E B Schoomaker.   

Abstract

Sixty healthy men in three physical fitness categories (sedentary, on no organized fitness program; joggers, running 5-15 miles/wk; and marathoners, running greater than 50 miles/wk) were evaluated for changes in blood clotting and fibrinolytic activity before and after maximum exercise on a treadmill according to the Bruce protocol. The rate of blood clotting, as measured by prothrombin times, partial thromboplastin times and thrombin times, was accelerated by exercise (all P less than 0.005). The ability of euglobulin clots and plasma clots to lyse incorporated 125I-fibrin, termed 125I-euglobulin clot lysis (IEL) and 125I-plasma clot lysis (IPCL), were used as indexes of fibrinolytic activity. Marathoners had greater increases in fibrinolytic activity with exercise (76% compared with 63% for joggers and 55% for sedentary subjects by IEL; 427% compared with 418% for joggers and 309% for sedentary subjects by IPCL; all P less than 0.05). Fibrin degradation products increased with exercise (P less than 0.005 for the total group of 60 subjects). The absolute concentrations of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, and antithrombin III increased with exercise (all P less than 0.005), but when concentrations were corrected for acute shifts of plasma water during exercise, the quantity of these inhibitors actually decreased (all P less than 0.005). The changes in clotting assays with exercise were not significantly correlated with changes in whole blood lactate, blood pyruvate, or rectal temperatures. Fibrinolytic assays before and after exercise correlated poorly to moderately with blood lactates (IEL: r = 0.441 and r = 0.425, respectively; IPCL: r = 0.294 and r = 0.544, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3597218     DOI: 10.1152/jappl.1987.62.4.1416

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

Review 1.  Exercise in cardiac rehabilitation.

Authors:  H J Bethell
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

Review 2.  Effects of strenuous exercise on haemostasis.

Authors:  J E Smith
Journal:  Br J Sports Med       Date:  2003       Impact factor: 13.800

3.  Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses.

Authors:  Cecilia I Perez-Moreno; Laurent L Couëtil; Suzanne M Pratt; Hugo G Ochoa-Acuña; Rose E Raskin; Mark A Russell
Journal:  Can Vet J       Date:  2009-08       Impact factor: 1.008

Review 4.  Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation.

Authors:  M S el-Sayed
Journal:  Sports Med       Date:  1996-11       Impact factor: 11.136

5.  Relation between cardiorespiratory fitness and selected risk factors for coronary heart disease in a population of Canadian men and women.

Authors:  M Jetté; K Sidney; J Quenneville; F Landry
Journal:  CMAJ       Date:  1992-04-15       Impact factor: 8.262

6.  The effect of different exercise intensities on the fibrinolytic system.

Authors:  A B Molz; B Heyduck; H Lill; E Spanuth; L Röcker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

7.  Factors determining case fatality in myocardial infarction "who dies in a heart attack"?

Authors:  G Wannamethee; P H Whincup; A G Shaper; M Walker; P W MacFarlane
Journal:  Br Heart J       Date:  1995-09

8.  Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery.

Authors:  D Wosornu; W Allardyce; D Ballantyne; P Tansey
Journal:  Br Heart J       Date:  1992-08

9.  Changes in the fibrinolytic system associated with physical conditioning.

Authors:  J A De Paz; J Lasierra; J G Villa; E Viladés; M A Martín-Nuño; J González-Gallego
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

10.  Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.

Authors:  Carolina Borges Garcia; Luciana Parente Costa Seguro; Luiz Augusto Perandini; Ana Lúcia de Sá Pinto; Fernanda Rodrigues Lima; Carlos Eduardo Negrão; Eloisa Bonfa; Eduardo Ferreira Borba
Journal:  Rheumatol Int       Date:  2014-05-14       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.